Search Results - "Rotundo MS"

Liposomal pegylated doxorubicin plus vinorelbine combination as first-line chemotherapy for metastatic breast cancer in elderly women >/=65 years of age.

Authors: Addeo R Faiola V Guarrasi R et al.

Source: Cancer Chemotherapy & Pharmacology. Jul2008, Vol. 62 Issue 2, p285-292. 8p.

URL: 31998872

Cisplatin plus capecitabine concomitant with intensity-modulated radiation therapy in non-metastatic anal squamous cell carcinoma: the experience of a single research cancer center.

Authors: Rotundo MS Zampino MG Ravenda PS et al.

Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2020 Jul 15; Vol. 12, pp. 1758835920940945. Date of Electronic Publication: 2020 Jul 15 (Print Publication: 2020).

Publication Type: Journal Article

Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE

Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.

Authors: Dell'Acqua V Surgo A Arculeo S et al.

Source: International journal of colorectal disease [Int J Colorectal Dis] 2020 Apr; Vol. 35 (4), pp. 685-694. Date of Electronic Publication: 2020 Feb 08.

Publication Type: Journal Article

Journal Info: Publisher: Springer International Country of Publication: Germany NLM ID: 8607899 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-1262 (Electronic) Linking ISSN: 01791958 NLM ISO Abbreviation: Int J Colorectal Dis Subsets: MEDLINE

PD-1/PD-L1 blockade, a novel strategy for targeting metastatic colorectal cancer: A systematic review and meta-analysis of randomized trials.

Authors: Rotundo MS Bagnardi V Rotundo M et al.

Source: Oncology letters [Oncol Lett] 2022 Apr; Vol. 23 (4), pp. 134. Date of Electronic Publication: 2022 Feb 23.

Publication Type: Journal Article

Journal Info: Publisher: Spandidos Publications] Country of Publication: Greece NLM ID: 101531236 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1792-1082 (Electronic) Linking ISSN: 17921074 NLM ISO Abbreviation: Oncol Lett Subsets: PubMed not MEDLINE

Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer.

Authors: Correale P Rotundo MS Botta C et al.

Source: Oncoimmunology [Oncoimmunology] 2012 Jul 01; Vol. 1 (4), pp. 531-532.

Publication Type: Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print Cited Medium: Print ISSN: 2162-4011 (Print) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: PubMed not MEDLINE

Single nucleotide polymorphisms of ABCC5 and ABCG1 transporter genes correlate to irinotecan-associated gastrointestinal toxicity in colorectal cancer patients: a DMET microarray profiling study.

Authors: Di Martino MT Arbitrio M Leone E et al.

Source: Cancer biology & therapy [Cancer Biol Ther] 2011 Nov 01; Vol. 12 (9), pp. 780-7. Date of Electronic Publication: 2011 Nov 01.

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients.

Authors: Correale P Botta C Basile A et al.

Source: Cancer biology & therapy [Cancer Biol Ther] 2011 Jul 15; Vol. 12 (2), pp. 112-8. Date of Electronic Publication: 2011 Jul 15.

Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

mTOR inhibitors, a new era for metastatic luminal HER2-negative breast cancer? A systematic review and a meta-analysis of randomized trials.

Authors: Rotundo MS Galeano T Tassone P et al.

Source: Oncotarget [Oncotarget] 2016 May 10; Vol. 7 (19), pp. 27055-66.

Publication Type: Journal Article; Meta-Analysis; Systematic Review

Journal Info: Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE

Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: the GOLFIG-2 multicentric open-label randomized phase III trial.

Authors: Correale P Botta C Rotundo MS et al.

Source: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2014 Jan; Vol. 37 (1), pp. 26-35.

Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

Tumor infiltration by T lymphocytes expressing chemokine receptor 7 (CCR7) is predictive of favorable outcome in patients with advanced colorectal carcinoma.

Authors: Correale P Rotundo MS Botta C et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2012 Feb 01; Vol. 18 (3), pp. 850-7. Date of Electronic Publication: 2011 Dec 05.

Publication Type: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Regulatory (FoxP3+) T-cell tumor infiltration is a favorable prognostic factor in advanced colon cancer patients undergoing chemo or chemoimmunotherapy.

Authors: Correale P Rotundo MS Del Vecchio MT et al.

Source: Journal of immunotherapy (Hagerstown, Md. : 1997) [J Immunother] 2010 May; Vol. 33 (4), pp. 435-41.

Publication Type: Clinical Trial, Phase III; Comparative Study; Journal Article; Randomized Controlled Trial

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9706083 Publication Model: Print Cited Medium: Internet ISSN: 1537-4513 (Electronic) Linking ISSN: 15249557 NLM ISO Abbreviation: J Immunother Subsets: MEDLINE

Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab and has strong antitumor activity in advanced non-small-cell-lung cancer patients.

Authors: Correale P Remondo C Carbone SF et al.

Source: Cancer biology & therapy [Cancer Biol Ther] 2010 May 01; Vol. 9 (9), pp. 685-93.

Publication Type: Clinical Trial, Phase I; Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

Second-line treatment of non small cell lung cancer by biweekly gemcitabine and docetaxel +/- granulocyte-macrophage colony stimulating factor and low dose aldesleukine.

Authors: Correale P Tindara Miano S Remondo C et al.

Source: Cancer biology & therapy [Cancer Biol Ther] 2009 Mar 15; Vol. 8 (6), pp. 497-502. Date of Electronic Publication: 2009 Mar 15.

Publication Type: Clinical Trial, Phase II; Journal Article

Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101137842 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1555-8576 (Electronic) Linking ISSN: 15384047 NLM ISO Abbreviation: Cancer Biol Ther Subsets: MEDLINE

Immunity feedback and clinical outcome in colon cancer patients undergoing chemoimmunotherapy with gemcitabine + FOLFOX followed by subcutaneous granulocyte macrophage colony-stimulating factor and aldesleukin (GOLFIG-1 Trial).

Authors: Correale P Tagliaferri P Fioravanti A et al.

Source: Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2008 Jul 01; Vol. 14 (13), pp. 4192-9.

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Print ISSN: 1078-0432 (Print) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE